$NRXP <$3.15 rn - FDA has revised the Generic Drugs User Fee Act (GDUFA) Goal Date to November 10, 2026. US FDA will have to approve NRX-100 that has been award

$NRXP <$3.15 rn - FDA has revised the Generic Drugs User Fee Act (GDUFA) Goal Date to November 10, 2026. US FDA will have to approve NRX-100 that has been awarded Fast Track Designation for the treatment of Suicidal ideation in Depression, including Bipolar Depression imo. Abbreviated New Drug Appli…